• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transarterial Embolization With or Without Chemotherapy: What Should Be the Indication for Patients With Hepatocellular Carcinoma?

作者信息

Zhong Jian-Hong, Tan Jun-Tao, Li Li-Qun, Wu Wen-Shu, Zhao Chang

机构信息

Jian-Hong Zhong, Jun-Tao Tan, and Li-Qun Li, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China; Wen-Shu Wu, University of Illinois College of Medicine at Chicago, Chicago, IL; and Chang Zhao, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China.

出版信息

J Clin Oncol. 2017 Jan 10;35(2):257-258. doi: 10.1200/JCO.2016.68.4902. Epub 2016 Oct 23.

DOI:10.1200/JCO.2016.68.4902
PMID:28056197
Abstract
摘要

相似文献

1
Transarterial Embolization With or Without Chemotherapy: What Should Be the Indication for Patients With Hepatocellular Carcinoma?经动脉栓塞术联合或不联合化疗：肝细胞癌患者的适应证应该是什么？
J Clin Oncol. 2017 Jan 10;35(2):257-258. doi: 10.1200/JCO.2016.68.4902. Epub 2016 Oct 23.
2
Chemoembolization or Bland Embolization for Hepatocellular Carcinoma: The Question Is Still Unanswered.化学栓塞术或单纯栓塞术治疗肝细胞癌：问题仍未得到解答。
J Clin Oncol. 2017 Jan 10;35(2):256-257. doi: 10.1200/JCO.2016.67.2915. Epub 2016 Oct 23.
3
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.多柔比星洗脱微球与单纯微球栓塞治疗肝细胞癌的肝动脉栓塞随机试验
J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1.
4
Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.化疗栓塞与放射性栓塞期间使用抗反流导管时血管腔血压变化的量化：一项回顾性病例系列研究
J Vasc Interv Radiol. 2017 Jan;28(1):103-110. doi: 10.1016/j.jvir.2016.08.007. Epub 2016 Nov 10.
5
Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.载阿霉素超吸收性聚合物微球经导管动脉化疗栓塞治疗肝细胞癌的中期随访
J Vasc Interv Radiol. 2014 Feb;25(2):248-55.e1. doi: 10.1016/j.jvir.2013.10.017. Epub 2013 Dec 2.
6
DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.经动脉化疗栓塞术治疗中晚期肝癌——巴西一家癌症中心的初步经验
Cancer Imaging. 2017 Feb 6;17(1):5. doi: 10.1186/s40644-017-0108-6.
7
[Hepatic carcinoma treated by hepatic arterial embolization using 131I and chemotherapeutic agent gelatin microspheres: report of 9 cases].[采用¹³¹I和化疗药物明胶微球经肝动脉栓塞治疗肝癌：9例报告]
Hua Xi Yi Ke Da Xue Xue Bao. 1992 Sep;23(4):420-3.
8
Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment.经动脉化疗栓塞治疗肝细胞癌后发生栓塞后综合征的危险因素
Acta Med Port. 2018 Jan 31;31(1):22-29. doi: 10.20344/amp.8976.
9
Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study.经肝动脉栓塞治疗后肝癌的腹腔内转移：一项观察性研究。
Abdom Radiol (NY). 2017 Jun;42(6):1794-1798. doi: 10.1007/s00261-017-1071-1.
10
[Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].多柔比星洗脱微球经动脉化疗栓塞术（DEB-TACE）与传统经动脉化疗栓塞术（TACE）治疗肝细胞癌的比较
Radiologia. 2011 May-Jun;53(3):246-53. doi: 10.1016/j.rx.2010.07.010. Epub 2011 Feb 4.

引用本文的文献

1
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers.卡博替尼联合或不联合帕尼单抗治疗 RAS 野生型转移性结直肠癌：MET 扩增对临床结局和循环生物标志物的影响。
Cancer Chemother Pharmacol. 2022 Mar;89(3):413-422. doi: 10.1007/s00280-022-04404-8. Epub 2022 Feb 16.